News

In this episode of Don’t Miss a Beat, hosts Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, provide a recap of the European Society of Cardiology Congress 2022. This recap begins with a discussion on the results of the phase 3 DELIVER trial, in which Vaduganathan served as an investigator, the ADVOR trial, and REVIVED.

People with diabetes in Italy and the UK reported the highest rates of anxiety at 63% and 51%, respectively.

Children identifying as Black, Mexican American, low-income, or non-US citizen were more likely to report poor subjective visual function from 2005 to 2008.

The investigators sequenced HBsAg and found no amino acid substitution.

Patients with pulmonary tuberculosis (TB) exhibited an improvement in quality of life and a reduction in treatment costs by utilizing a digital medication event reminder monitor (MERM).

It is the first FDA-approved product indicated to improve kidney function in adults with HRS.

There has been a significant increase of IBD overall and Crohn’s disease specifically in pediatric patients between 2000-2014.

Dr. Sara Mednick's pursuit to understand how to improve intelligence led her to an extensive career of studying the various mechanisms of sleep.

Model results were sensitive to the probability of hernia recurrence and hernia incarceration and utility decrement in the symptomatic hernia state.

Short-term treatment with rosuvastatin was not linked to changes in insulin resistance markers in a cohort of children with familial hypercholesterolemia.

Individuals were more likely to communicate about sleep during depressed mood episodes.

Dr. Mednick's latest book, The Power of the Downstate, focuses on the integrated role of sleep by following the "rhythm of upstates and downstates" that people operate in every day.

Cases and hospitalizations due to EV-D68, a rare form of enterovirus associated with acute flaccid myelitis (AFM), have been increasing among children across the country.

Study data suggest the observed to expected ratio of VAU for the United States cases reports was comparable for all 3 approved vaccines.

Individuals who reported three cumulative insomnia symptoms of DIS, DSM and NRS had 40% increased risk of future bloodstream infection.

Patients with both COVID-19 and HBV had a significantly higher in-hospital mortality rate and were more likely to develop severe disease compared to patients with only COVID-19 infections.

Malnutrition rates were similar between patients with ulcerative colitis and patients with Crohn’s disease.

Nonpharmacological sleep interventions that focused on earlier sleep schedules can serve as a “simple, pragmatic, effective way to meaningfully increase sleep duration that could have important benefits for child health.”

Acadia Pharmaceuticals announced that the FDA granted a priority review for trofinetide and set March 12, 2023 as the PDUFA date.

Children in the RLRL group had less myopia progression and axial elongation compared with those in the sham device control group.

The presence of SRF or PED was not significantly associated with worse visual acuity at any time point during the observation period.

The novel OX40 inhibitor molecule showed significant benefit for patients in new EADV 2022 data. A lead author discusses its potential.

The highest global cirrhosis prevalence was found in the East and Southeast Asia, mainly caused by high levels of hepatitis prevalence in those areas.

The daily TYK2 inhibitor agent was associated with improved rates of psoriasis surface improvement versus apremilast in clinical trials.

The FDA accepted the Biologics License Application (BLA) and granted priority review for velmanase alfa, an investigational enzyme replacement therapy intended to treat the ultra rare disease.

The Icahn investigator discusses her team's new EADV 2022 data on the JAK inhibitor.

Black/African American individuals are more likely to have an amputation within the first year following DFU, while women appeared to have a greater likelihood of delayed amputation.

Eyes with preoperative inner microcystoid changes had significantly worse postoperative and final visual acuity.